![Joanne Kurtzberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanne Kurtzberg
Directeur Technique/Scientifique/R&D chez
CRYO-CELL INTERNATIONAL, INC.
Profil
Currently, Joanne Kurtzberg is Medical Director at Cryo-Cell International, Inc. since 2018, Director at Marcus Center For Cellular Cures, Jerome S.
Harris Professor-Pediatrics at Duke University, and President of the Cord Blood Association.
Formerly, Dr. Kurtzberg was Director at The Foundation For The Accreditation of Cellular Therapy.
Postes actifs de Joanne Kurtzberg
| Sociétés | Poste | Début |
|---|---|---|
| CRYO-CELL INTERNATIONAL, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cord Blood Association
 Cord Blood Association Medical/Nursing ServicesHealth Services The Cord Blood Association operates under the umbrella of the Association for the Advancement of Blood & Biotherapies (AABB), an international nonprofit organization dedicated to advancing transfusion medicine and biotherapies. The private company is based in Geneva, IL. AABB supports the mission of the Cord Blood Association by providing standards, accreditation, education, and advocacy focused on cord blood and cellular therapies. The organization offers resources and professional development opportunities, including certification programs, educational sessions, and a dedicated cord blood committee. AABB’s accreditation programs help institutions demonstrate quality and safety in cord blood and cellular therapy services. The organization promotes collaboration and innovation through corporate partnerships, mentorship programs, and volunteer opportunities, aiming to advance clinical applications of cord blood and birth tissue therapies. AABB emphasizes lifelong learning, workforce development, regulatory guidance, and evidence-based practices to ensure that transfusion medicine and biotherapies are safe, available, and effective worldwide. | President | - |
Marcus Center For Cellular Cures
 Marcus Center For Cellular Cures Medical/Nursing ServicesHealth Services The Marcus Center for Cellular Cures (MC3) at Duke University is a collaborative initiative between Duke’s School of Medicine and Pratt School of Engineering focused on developing cellular and biological therapies for diseases and injuries that lack effective treatments. The private company is based in Durham, NC. MC3 addresses conditions such as autism, cerebral palsy, stroke, multiple sclerosis, leukodystrophies, lysosomal storage disorders, and other brain and metabolic disorders. The center integrates multidisciplinary research laboratories that conduct preclinical and translational studies on cellular therapies, immune interactions, and tissue biology. It operates two FDA-registered, FACT-accredited good manufacturing practice laboratories that produce clinical-grade biologic products and support clinical trials. MC3 manages clinical trial programs investigating umbilical cord blood and tissue-derived cell therapies for neurological and metabolic diseases, and oversees donor screening and regulatory affairs. The Carolinas Cord Blood Bank (CCBB), part of MC3, collects, processes, and stores cord blood units for transplantation and research, supporting hematopoietic stem cell transplants and clinical trials. | Directeur/Membre du Conseil | - |
Anciens postes connus de Joanne Kurtzberg
| Sociétés | Poste | Fin |
|---|---|---|
The Foundation For The Accreditation of Cellular Therapy
 The Foundation For The Accreditation of Cellular Therapy The Foundation For The Accreditation of Cellular Therapy is a non-profit company based in Omaha, NE. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cryo-Cell International, Inc.
 Cryo-Cell International, Inc. Other TransportationTransportation Engages in cellular processing and cryogenic storage | Transportation |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Foundation For The Accreditation of Cellular Therapy
The Foundation For The Accreditation of Cellular Therapy The Foundation For The Accreditation of Cellular Therapy is a non-profit company based in Omaha, NE. | |
Cord Blood Association
Cord Blood Association Medical/Nursing ServicesHealth Services The Cord Blood Association operates under the umbrella of the Association for the Advancement of Blood & Biotherapies (AABB), an international nonprofit organization dedicated to advancing transfusion medicine and biotherapies. The private company is based in Geneva, IL. AABB supports the mission of the Cord Blood Association by providing standards, accreditation, education, and advocacy focused on cord blood and cellular therapies. The organization offers resources and professional development opportunities, including certification programs, educational sessions, and a dedicated cord blood committee. AABB’s accreditation programs help institutions demonstrate quality and safety in cord blood and cellular therapy services. The organization promotes collaboration and innovation through corporate partnerships, mentorship programs, and volunteer opportunities, aiming to advance clinical applications of cord blood and birth tissue therapies. AABB emphasizes lifelong learning, workforce development, regulatory guidance, and evidence-based practices to ensure that transfusion medicine and biotherapies are safe, available, and effective worldwide. | Health Services |
Marcus Center For Cellular Cures
Marcus Center For Cellular Cures Medical/Nursing ServicesHealth Services The Marcus Center for Cellular Cures (MC3) at Duke University is a collaborative initiative between Duke’s School of Medicine and Pratt School of Engineering focused on developing cellular and biological therapies for diseases and injuries that lack effective treatments. The private company is based in Durham, NC. MC3 addresses conditions such as autism, cerebral palsy, stroke, multiple sclerosis, leukodystrophies, lysosomal storage disorders, and other brain and metabolic disorders. The center integrates multidisciplinary research laboratories that conduct preclinical and translational studies on cellular therapies, immune interactions, and tissue biology. It operates two FDA-registered, FACT-accredited good manufacturing practice laboratories that produce clinical-grade biologic products and support clinical trials. MC3 manages clinical trial programs investigating umbilical cord blood and tissue-derived cell therapies for neurological and metabolic diseases, and oversees donor screening and regulatory affairs. The Carolinas Cord Blood Bank (CCBB), part of MC3, collects, processes, and stores cord blood units for transplantation and research, supporting hematopoietic stem cell transplants and clinical trials. | Health Services |
